Welcome to CDC stacks | 1 needle + 1 syringe + 1 time = 0 infections - 43018 | Stephen B. Thacker CDC Library collection
Stacks Logo
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.
 
 
Help
Clear All Simple Search
Advanced Search
1 needle + 1 syringe + 1 time = 0 infections
Filetype[PDF-495.46 KB]


Details:
  • Supporting Files:
    No Additional Files
No Related Documents.
You May Also Like:
  1. The Public health impact of needle exchange programs in the United States and abroad; summary, conclusions, and recommendations
    Corporate Author:
    University of California, Berkeley, School of Public Health.; University of California, San Francisco, Institute for Health Policy Studies.; Centers for Disease Control and Prevention (U.S.);
    Published:
    1993
    Description:
    Prepared for the Centers for Disease Control and Prevention. Funded through a cooperative agreement with the Association of Schools of Public Health (ASPH Agreement No. M1589). : The current evaluation was funded through a cooperative agreement betwe...
    File Type:
    Filetype[PDF - 132.79 KB]
  2. Preventing blood-borne infections through pharmacy syringe sales and safe community syringe disposal
    Corporate Author:
    American Pharmaceutical Association; Centers for Disease Control and Prevention (U.S.);
    Published:
    November/December 2002
    Series:
    Journal of the American Pharmaceutical Association ; v. 42, no. 6, Suppl. 2
    Description:
    "This supplement to the November–December 2002 issue of JAPhA highlights pharmacy and public health cooperation to increase pharmacy syringe sales to injection drug users and to promote safe community syringe disposal." : "Publication of this suppl...
    File Type:
    Filetype[PDF - 1.06 MB]
  3. Guidance on prevention of viral hepatitis B and C among people who inject drugs
    Corporate Author:
    World Health Organization, Department of HIV/AIDS.; Centers for Disease Control and Prevention (U.S.); United States, President's Emergency Plan for AIDS Relief.; World Health Organization;
    Published:
    July 2012
    Description:
    This Guidance on prevention of viral hepatitis B and C among people who inject drugs is the first step in the provision of comprehensive guidance on viral hepatitis surveillance, prevention and treatment by the World Health Organization. These recomm...
    File Type:
    Filetype[PDF - 1.68 MB]
  4. HIV and STI Prevalence and Injection Behaviors Among People Who Inject Drugs in Nairobi: Results from a 2011 Bio-behavioral Study Using Respondent-Driven Sampling
    Personal Author:
    Tun, Waimar; Sheehy, Meredith; Broz, Dita; Okal, Jerry; Muraguri, Nicholas; Raymond, H. Fisher; Musyoki, Helgar; Kim, Andrea A.; Muthui, Mercy; Geibel, Scott;
    Published:
    Feb 2015
    Source:
    AIDS Behav. 19(Suppl 1):24-35.
    Description:
    There is a dearth of evidence on injection drug use and associated HIV infections in Kenya. To generate population-based estimates of characteristics and HIV/STI prevalence among people who inject drugs (PWID) in Nairobi, a cross-sectional study was ...
    File Type:
    Filetype[PDF - 364.37 KB]
  5. HIV, Hepatitis C, and Hepatitis B Infections and Associated Risk Behavior in Injection Drug Users, Kabul, Afghanistan
    Personal Author:
    Todd, Catherine S.; Abed, Abdullah M.S.; Strathdee, Steffanie A.; Scott, Paul T.; Botros, Boulos A.; Safi, Naqibullah; Earhart, Kenneth C.;
    Published:
    Sep 2007
    Source:
    Emerg Infect Dis. 13(9):1327-1331.
    Description:
    Limited prevalence data for HIV, hepatitis B surface antigen (HBsAg), and hepatitis C virus (HCV) exist for Afghanistan. We studied a cross-sectional sample of adult injection drug users (IDUs) in Kabul, Afghanistan, from June 2005 through June 2006....
    File Type:
    Filetype[PDF - 281.24 KB]